<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[Dyadic International Inc. | Company News & Executive Profiles - DYAI | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/dyadic+international+inc..html?i=11]]></link>
	<description><![CDATA[Latest company news & analysis, recent events, stock quotes, earning call transcripts, with profiles and descriptions of top business executives for Dyadic International Inc.]]></description>
	<s:counts start="0" returned="10" found="18" />
	<language>en-us</language>
	<item>
		<title><![CDATA[Dyadic International, Inc. Announces Changes to Its Board of Directors]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2008_March_14/ai_n24923061]]></link>
		<description><![CDATA[JUPITER, Fla. -- Dyadic International, Inc. (the "Company") today announced the election of Mr. Wendell H. Adair, Jr., to the Board of Directors (the "Board") of the Company. Mr. Adair replaces Mr. Richard J. Berman, who has resigned from the Board.  On March 14, 2008, the Executive Committee (the...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Fri, 14 Mar 2008 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/board.html"><![CDATA[board]]></category>
		<category domain="http://resources.bnet.com/topic/company.html"><![CDATA[Company]]></category>
		<category domain="http://resources.bnet.com/topic/director.html"><![CDATA[director]]></category>
		<category domain="http://resources.bnet.com/topic/dyadic+international+inc..html"><![CDATA[Dyadic International Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/sec.html"><![CDATA[SEC]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">DYAI</category>
		<category domain="tickers">DYAI</category>
	</item>
	<item>
		<title><![CDATA[Berman DeValerio Announces Shareholder Suit Against Dyadic International, Inc.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_pwwi/is_200711/ai_n21123734]]></link>
		<description><![CDATA[An investor has sued Dyadic International, Inc. ("Dyadic" or the "Company") (AMEX: DIL) in federal court, accusing the company of securities law violations, Berman DeValerio announced today.  Berman DeValerio ( www.bermanesq.com ) filed the class action complaint on November 21, 2007 in the Southern District of Florida. The complaint,...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 26 Nov 2007 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/company.html"><![CDATA[Company]]></category>
		<category domain="http://resources.bnet.com/topic/dyadic+international+inc..html"><![CDATA[Dyadic International Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/sec.html"><![CDATA[SEC]]></category>
		<category domain="http://resources.bnet.com/topic/security.html"><![CDATA[security]]></category>
		<category domain="http://resources.bnet.com/topic/shareholder.html"><![CDATA[shareholder]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">DYAI</category>
		<category domain="tickers">DYAI</category>
	</item>
	<item>
		<title><![CDATA[Dyadic to Present at The BIO CEO & Investor Conference Monday, February 12, 2007, At 11:45 A.M. EST]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2007_Feb_9/ai_n27143908]]></link>
		<description><![CDATA[Webcast Will Be Available At www.dyadic.com  JUPITER, Fla. -- Dyadic International, Inc. (Amex:DIL), a global biotechnology company, announced today that CEO Mark Emalfarb will make a presentation to investors at the BIO CEO & Investor Conference at the Waldorf-Astoria Hotel in New York City, on Monday, February 12, 2007,...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Fri, 09 Feb 2007 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/ceo.html"><![CDATA[CEO]]></category>
		<category domain="http://resources.bnet.com/topic/dyadic+international+inc..html"><![CDATA[Dyadic International Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/investor.html"><![CDATA[investor]]></category>
		<category domain="http://resources.bnet.com/topic/sec.html"><![CDATA[SEC]]></category>
		<category domain="http://resources.bnet.com/topic/webcast.html"><![CDATA[Webcast]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">DYAI</category>
		<category domain="tickers">DYAI</category>
	</item>
	<item>
		<title><![CDATA[Dyadic to Present at The AMEX First Annual Healthcare Investor Conference Thursday, February 8, 2007, at 10:05 A.M. EST]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2007_Feb_5/ai_n17167331]]></link>
		<description><![CDATA[Webcast Will Be Available at www.dyadic.com  JUPITER, Fla. -- Dyadic International, Inc. (AMEX:DIL), a global biotechnology company, announced today that CEO Mark Emalfarb will make a presentation to investors at The American Stock Exchange's First Annual Healthcare Investor Conference at the Fairmont Copley Plaza, Boston, on Thursday, February 8,...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 05 Feb 2007 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/dyadic+international+inc..html"><![CDATA[Dyadic International Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/investor.html"><![CDATA[investor]]></category>
		<category domain="http://resources.bnet.com/topic/sec.html"><![CDATA[SEC]]></category>
		<category domain="http://resources.bnet.com/topic/webcast.html"><![CDATA[Webcast]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">DYAI</category>
		<category domain="tickers">DYAI</category>
	</item>
	<item>
		<title><![CDATA[Dyadic Closes $13 Million Private Placement]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2006_Dec_1/ai_n16880801]]></link>
		<description><![CDATA[JUPITER, Fla. -- Dyadic International, Inc. (AMEX:DIL), a biotechnology company, announced today that it has closed the previously announced private placement with institutional investors of 2,787,000 shares of common stock and warrants to purchase up to 557,400 shares of common stock for gross proceeds of $13,043,160. The warrants will become...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Fri, 01 Dec 2006 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/dyadic+international+inc..html"><![CDATA[Dyadic International Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/sec.html"><![CDATA[SEC]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">DYAI</category>
		<category domain="tickers">DYAI</category>
	</item>
	<item>
		<title><![CDATA[Dyadic Closes $10 Million R&D and Stock Purchase Agreement with Abengoa Bioenergy in the Area of Cellulosic Ethanol Production]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2006_Nov_9/ai_n27044537]]></link>
		<description><![CDATA[JUPITER, Fla. -- Dyadic International, Inc. (AMEX:DIL), a biotechnology company, announced today that it has closed the previously announced three-year research and development (R&D) agreement and stock purchase agreement with Abengoa Bioenergy R&D, Inc. Abengoa, an Abengoa Bioenergy Company. Under the terms of the stock purchase agreement, Abengoa Bioenergy has...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 09 Nov 2006 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/agreement.html"><![CDATA[agreement]]></category>
		<category domain="http://resources.bnet.com/topic/dyadic+international+inc..html"><![CDATA[Dyadic International Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/r%2526d.html"><![CDATA[R&D]]></category>
		<category domain="http://resources.bnet.com/topic/sec.html"><![CDATA[SEC]]></category>
		<category domain="http://resources.bnet.com/topic/stock.html"><![CDATA[stock]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">DYAI</category>
		<category domain="tickers">DYAI</category>
	</item>
	<item>
		<title><![CDATA[Pinnacle's Review of Dyadic International Inc.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5243/is_200611/ai_n19650902]]></link>
		<description><![CDATA[M2 PRESSWIRE-8 November 2006-Pinnacle Digest: Pinnacle's  Review of Dyadic International Inc.C1994-2006 M2 COMMUNICATIONS LTD    RDATE:08112006    Dyadic International Inc. (AMEX:DIL) is a biotechnology company  poised to become a global leader in proteomics through the discovery,  development, and manufacturing of novel products derived...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 08 Nov 2006 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/abengoa+s.a..html"><![CDATA[Abengoa S.A.]]></category>
		<category domain="http://resources.bnet.com/topic/dyadic+international+inc..html"><![CDATA[Dyadic International Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">DYAI</category>
		<category domain="tickers">DYAI</category>
	</item>
	<item>
		<title><![CDATA[Dyadic Granted Patent for High-Throughput Screening of Expressed DNA Libraries in Filamentous Fungi]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2006_Oct_19/ai_n27034278]]></link>
		<description><![CDATA[Expands Patent Protection for Dyadic's C1 Host Technology Platform for Applications in Cellulosic Ethanol and Other Key Markets  JUPITER, Fla. -- Dyadic International, Inc. (AMEX:DIL), a biotechnology company, announced today that it was granted U.S. patent 7,122,330, "High-Throughput Screening of Expressed DNA Libraries in Filamentous Fungi," by the U.S....]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 19 Oct 2006 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotechnology.html"><![CDATA[Biotechnology]]></category>
		<category domain="http://resources.bnet.com/topic/dna.html"><![CDATA[DNA]]></category>
		<category domain="http://resources.bnet.com/topic/dyadic+international+inc..html"><![CDATA[Dyadic International Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/fungi.html"><![CDATA[fungi]]></category>
		<category domain="http://resources.bnet.com/topic/protein.html"><![CDATA[protein]]></category>
		<category domain="http://resources.bnet.com/topic/sec.html"><![CDATA[SEC]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">DYAI</category>
		<category domain="tickers">DYAI</category>
	</item>
	<item>
		<title><![CDATA[Dyadic to Present at the Sanders Morris Harris Investor Growth Conference on October 23, 2006 at 10:00 a.m. EDT]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2006_Oct_17/ai_n27037254]]></link>
		<description><![CDATA[Webcast will be available at www.dyadic.com  JUPITER, Fla. -- Dyadic International, Inc. (AMEX:DIL), a biotechnology company, announced today that Mark Emalfarb, Dyadic's President and Chief Executive Officer, will make a presentation at the Sanders Morris Harris Investor Growth Conference to be held in New York City at the Omni...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 17 Oct 2006 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/dyadic+international+inc..html"><![CDATA[Dyadic International Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/sec.html"><![CDATA[SEC]]></category>
		<category domain="http://resources.bnet.com/topic/webcast.html"><![CDATA[Webcast]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">DYAI</category>
		<category domain="tickers">DYAI</category>
	</item>
	<item>
		<title><![CDATA[Dyadic to Present at the ThinkEquity Partners 4th Annual Growth Conference on September 14, 2006 at 11:00 a.m. PDT ; Webcast Will Be Available at www.dyadic.com]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2006_Sept_8/ai_n26980534]]></link>
		<description><![CDATA[JUPITER, Fla. -- Dyadic International, Inc. (AMEX:DIL), a biotechnology company, announced today that Glenn Nedwin, Ph.D, Dyadic's Chief Scientific Officer, Executive Vice President and President of Dyadic's Biosciences Business, will make a presentation at the ThinkEquity Partners 4th Annual Growth Conference to be held at the Ritz Carlton Hotel in...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Fri, 08 Sep 2006 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotechnology.html"><![CDATA[Biotechnology]]></category>
		<category domain="http://resources.bnet.com/topic/dr..html"><![CDATA[Dr.]]></category>
		<category domain="http://resources.bnet.com/topic/dyadic+international+inc..html"><![CDATA[Dyadic International Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/sec.html"><![CDATA[SEC]]></category>
		<category domain="http://resources.bnet.com/topic/webcast.html"><![CDATA[Webcast]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">DYAI</category>
		<category domain="tickers">DYAI</category>
	</item>
</channel>
</rss>
